// App-Quantinova.ai

PB1753 : UNCERTAINTY ABOUT THE FUTURE: INSIGHTS FROM OLDER PATIENTS WITH ACUTE MYELOID LEUKAEMIA (AML) ON DIFFERENT TREATMENT PATHS

Researchers

Presenter

  • Roland B. Walter

Principal Investigators

  • Dawn Maze

  • Diana Merino Vega

  • Timothy J. Bell

  • Julia Stein

  • Karim Amer

  • Lucy Morgan

  • Francois Peloquin

  • Loriana Hernandez-Aldama

  • Jasmine Healy

  • Charlotte Panter

  • Verna Welch

  • Adam Gater

  • Ryan Hohman

  • Louise O'Hara

  • Andrew Brown

  • Thomas W. LeBlanc

  • Nigel H. Russell

Medical Centers

  • Adelphi Values, Bollington, United Kingdom

  • Department of Medical Oncology and Hematology,Princess Margaret Cancer Centre,Ontario,Canada

  • Pfizer Inc., New York, United States

  • Pfizer Canada ULC,Kirkland,Canada

  • Division of Hematological Malignancies and Cellular Therapy, Department of Medicine,Duke University School of Medicine,Durham,United States

  • Department of Haematology,Guy's Hospital,London,United Kingdom

  • Friends of Cancer Research,Washington,United States

  • Fred Hutchinson Cancer Research Center, Seattle, WA, United States

  • Pfizer Inc., Tadworth, United Kingdom

  • ArmorUp for LIFE,Philadelphia,United States

Locations

  • United Kingdom

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A